department of pharmacology st marys hospital medical school university of london norfolk place london w ipg tele phone j msic jias il oth march dr sheldon csommers pobox alpine new jerscy usa dear charlie since returning t london my colleague jackie pontin i have given more thought t how best to capitalize upon the studics on high and low familial risk of lung cancer which are just being set up with henry lynch since dr lynch will bc taking the trouble of mounting the field studies in various types of high and low risk cancer pedigrecs fecl strongly that wc should not miss the opportunity of esta blishing immortal cell lines on each cf the subjects which we will study such is my conviction that i believe these studics should be started immediately and not constrained by my movc to newcastle herc is my proposal omaha will be recruiting subjects each phenotyped with debrisoquine in vivo they will fall into four groups of equal size sporadic lung cancers with no other cincer family history low risk sporadic iung cancers with positive cancer family history colon cancerprone families with high low family histories these latter two typcs of pedigrec are very intercsting from the following point of view that of the members of the kindreds therc is one known case of lung cancer immortalized ebvtransformed lymphoblastoid bcell lines will providc a future resource for studying thc molecular genetics of lung cancer risk we are already looking in cohorts with cdna probcs and rplp analysis for various po polymorphisms which wc believe may bcar upon lung cancer risk at rclatively small additional cost supplemented by ctr dr lynch could mail us small batches of fresh blood for bcell transformation cannot sce how this should add more than about s to the cost of cach sample collection or s in toto but he needs to be asked at our cnd wc shall need ms pontins salary with oncosts s for months togcther with consumable costs for cell trangformation culture and cryopreservation of s per ccll line cf soo nih contracted out costl s in addition we would need to purchase liquid nitrogen dewar for storing the cell lincs s the total cost of the project for the first ycar would thus be so profeasor of biochemical pharmacology robert l smith reader in drug metabolism john caldwell reader in pharmacogenetics jefirey r idle leccurer in pharracology toxicology stephen c mitchel lecturer in pharmacology j martin elliott chief mlso lawrence a wakilc and and only ie